Physician profile
Michael Nejat
NPI 1871576025
$7,461.90
in general payments reported to CMS, 2019-2025
20 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $153 · 2021: $416 · 2022: $992 · 2023: $813 · 2024: $2,847 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,816 · Travel and Lodging: $1,124 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,815.50 |
| Travel and Lodging | $1,123.87 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,301.80 | 2019-2025 | Lensx, Clareon, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $658.50 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Bausch & Lomb Americas INC. | $200.80 | 2022-2025 | Miebo, Vyzulta, Lotemax Sm |
| Rayner Intraocular Lenses Limited | $184.87 | 2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Tarsus Pharmaceuticals, INC. | $184.44 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $133.63 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $131.83 | 2021-2025 | |
| Dompe US, INC. | $117.80 | 2022-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $99.30 | 2019-2022 | |
| Harrow Eye, LLC | $92.04 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $59.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $53.16 | 2019 | |
| Abbvie INC. | $44.67 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.14 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $37.94 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $30.77 | 2020 | |
| Rxsight INC | $26.64 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Sight Sciences, INC. | $25.43 | 2023 | Tearcare System |
| Csl Behring | $21.62 | 2022 | |
| Shire North American Group INC | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nejat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.